Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

CervoMed (CRVO) FCF Margin (2023 - 2025)

CervoMed (CRVO) has disclosed FCF Margin for 7 consecutive years, with 75357.54% as the latest value for Q4 2025.

  • Quarterly FCF Margin fell 7498516.0% to 75357.54% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 585.3% through Dec 2025, down 41554.0% year-over-year, with the annual reading at 585.3% for FY2025, 41554.0% down from the prior year.
  • FCF Margin hit 75357.54% in Q4 2025 for CervoMed, down from 2004.29% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 60.65% in Q1 2024 to a low of 75357.54% in Q4 2025.
  • Historically, FCF Margin has averaged 6591.93% across 3 years, with a median of 158.58% in 2023.
  • Biggest five-year swings in FCF Margin: soared 4712bps in 2024 and later tumbled -7498516bps in 2025.
  • Year by year, FCF Margin stood at 101.92% in 2023, then tumbled by -265bps to 372.38% in 2024, then tumbled by -20137bps to 75357.54% in 2025.
  • Business Quant data shows FCF Margin for CRVO at 75357.54% in Q4 2025, 2004.29% in Q3 2025, and 370.63% in Q2 2025.